Pillstats
Rx only · Injection, Solution · Intramuscular

Morphine Sulfate

Morphine Sulfate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US10 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN02AA01
RxCUI (US)7052
US makers1 labelers
Packages5
DEA / ScheduleCII

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

10.0K20K30K40K2025 Q12025 Q22025 Q32025 Q42026 Q1
30K
Rx · 2026 Q1
95K
Units dispensed
-15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fresenius Kabi USA, LLCunknown5SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 17, 2021
    RECALLRecall (Class II): Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, ND…

    Defective container: Cracked vials leading to lack of sterility assurance — Recalling firm: Fresenius Kabi USA LLC — U.S.A. Nationwide

  • Oct 31, 2017
    SHORTAGEDrug shortage: Morphine Sulfate Injection (Fresenius Kabi USA, LLC)

    Morphine Sulfate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Analgesia/Addiction.